---
title: "Key deals this week: SPGI, PSO, GEHC, and more"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/299545740.md"
description: "This week saw significant M&A activity across sectors. S&P Global acquired OpenZeppelin, while Pearson bought ITS. GE HealthCare is in advanced talks to acquire Sofie Biosciences for ~$1B. Brookfield agreed to buy Reliance Worldwide for $2.9B. Aethlon Medical merged with North Immunology, and Infillion acquired Foursquare. Mistras Group will be acquired by H.I.G. Capital for $866M. China Rare Earth Group is negotiating to acquire Shenghe Resources."
datetime: "2026-09-20T06:59:58.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/299545740.md)
  - [en](https://longbridge.com/en/news/299545740.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/299545740.md)
generator: "portal-rs"
---

# Key deals this week: SPGI, PSO, GEHC, and more


### Related Stocks

- [GEHC.US](https://longbridge.com/en/quote/GEHC.US.md)
- [AEMD.US](https://longbridge.com/en/quote/AEMD.US.md)
- [MG.US](https://longbridge.com/en/quote/MG.US.md)
- [600392.CN](https://longbridge.com/en/quote/600392.CN.md)
- [RWC.AU](https://longbridge.com/en/quote/RWC.AU.md)
- [PSO.US](https://longbridge.com/en/quote/PSO.US.md)
- [SPGI.US](https://longbridge.com/en/quote/SPGI.US.md)
- [BN.US](https://longbridge.com/en/quote/BN.US.md)

## Related News & Research

- [GE HealthCare announces five new global collaborations to advance the next generation of theranostics imaging | GEHC Stock News](https://longbridge.com/en/news/302449419.md)
- [BDF Gestion Makes New Investment in GE HealthCare Technologies Inc. $GEHC](https://longbridge.com/en/news/302313418.md)
- [S&P Global declares $0.45 dividend](https://longbridge.com/en/news/302818116.md)
- [S&P Global completes acquisition of OpenZeppelin](https://longbridge.com/en/news/303080357.md)
- [RBC Capital Sticks to Its Buy Rating for S&P Global (SPGI)](https://longbridge.com/en/news/302156835.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**